Abiomed is a global leader in healthcare technology and innovation, with a focus on developing groundbreaking technologies to assist or replace the life-sustaining pumping function of the failing heart. Led by CEO, Chairman, and President Michael R. Minogue, the company offers a portfolio of products and services that provide healthcare professionals with an array of choices across a broad clinical spectrum. Abiomed's products range from the world's first total replacement heart to the World's Smallest Heart Pump, which is 1/100th the size of the heart and can be rapidly and easily inserted. The company is dedicated to bringing the most advanced and beneficial technology to patients and physicians alike with its mission of RECOVERING HEARTS AND SAVING LIVES.